Joseph Shulman's Insider Trades & SAST Disclosures
Joseph Shulman's most recent trade in Rhythm Pharmaceuticals Inc. was a trade of 37,500 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joseph Shulman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 37,500 | 37,500 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 4,125 | 12,375 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 4,125 | 9,737 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 57.22 per share. | 14 Feb 2025 | 1,228 | 8,509 (0%) | 0% | 57.2 | 70,266 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 56.39 per share. | 12 Feb 2025 | 462 | 5,619 (0%) | 0% | 56.4 | 26,052 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 57.14 per share. | 12 Feb 2025 | 7 | 5,612 (0%) | 0% | 57.1 | 400 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 2,656 | 5,313 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 2,656 | 2,656 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 1,562 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 1,562 | 6,875 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 57.51 per share. | 09 Feb 2025 | 791 | 6,084 (0%) | 0% | 57.5 | 45,490 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 57.67 per share. | 09 Feb 2025 | 3 | 6 (0%) | 0% | 57.7 | 173 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,938 | 7,874 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,938 | 3,938 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 59.43 per share. | 01 Feb 2025 | 1,281 | 2,657 (0%) | 0% | 59.4 | 76,130 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 7,969 | 19,922 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 11 Nov 2024 | 7,969 | 7,969 (0%) | 0% | 6.8 | 54,189 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 65.73 per share. | 11 Nov 2024 | 6,604 | 6,677 (0%) | 0% | 65.7 | 434,075 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 67.05 per share. | 11 Nov 2024 | 5,977 | 700 (0%) | 0% | 67.1 | 400,782 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 11 Nov 2024 | 5,312 | 13,281 (0%) | 0% | 21.4 | 113,571 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 5,312 | 0 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 67.83 per share. | 11 Nov 2024 | 700 | 0 (0%) | 0% | 67.8 | 47,484 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.35 per share. | 16 Jul 2024 | 10,468 | 10,498 (0%) | 0% | 27.4 | 286,300 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 10,468 | 23,032 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 53.00 per share. | 16 Jul 2024 | 10,468 | 30 (0%) | 0% | 53.0 | 554,817 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 12 Jul 2024 | 5,313 | 5,343 (0%) | 0% | 21.4 | 113,592 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 12 Jul 2024 | 5,313 | 30 (0%) | 0% | 50.0 | 265,725 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2024 | 5,313 | 1,297 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 09 May 2024 | 3,984 | 4,014 (0%) | 0% | 6.8 | 27,091 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 3,984 | 31,875 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 38.38 per share. | 09 May 2024 | 3,484 | 530 (0%) | 0% | 38.4 | 133,708 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 39.10 per share. | 09 May 2024 | 500 | 30 (0%) | 0% | 39.1 | 19,551 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 40.34 per share. | 21 Mar 2024 | 18,235 | 30 (0%) | 0% | 40.3 | 735,600 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 39.22 per share. | 19 Mar 2024 | 15,515 | 18,265 (0%) | 0% | 39.2 | 608,498 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 50,250 | 50,250 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 33,750 | 33,780 (0%) | 0% | 0 | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 16,500 | 16,500 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 13 Feb 2024 | 1,865 | 1,119 (0%) | 0% | 50 | 93,250 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 13 Feb 2024 | 1,089 | 30 (0%) | 0% | 50.0 | 54,461 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 69,190 | 6,610 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 09 Feb 2024 | 69,190 | 74,460 (0%) | 0% | 21.4 | 1,479,282 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 09 Feb 2024 | 65,175 | 70,415 (0%) | 0% | 21.4 | 1,393,442 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 65,175 | 10,625 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.14 per share. | 09 Feb 2024 | 48,177 | 26,183 (0%) | 0% | 50.1 | 2,415,503 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.88 per share. | 09 Feb 2024 | 23,397 | 2,786 (0%) | 0% | 50.9 | 1,190,503 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 3,985 | 31,875 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 09 Feb 2024 | 3,985 | 74,430 (0%) | 0% | 6.8 | 27,098 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,656 | 5,312 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,656 | 5,270 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 1,562 | 4,248 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 1,562 | 1,562 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 51.38 per share. | 09 Feb 2024 | 791 | 3,457 (0%) | 0% | 51.4 | 40,642 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 49.84 per share. | 09 Feb 2024 | 473 | 2,984 (0%) | 0% | 49.8 | 23,574 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 48.24 per share. | 09 Feb 2024 | 100 | 74,360 (0%) | 0% | 48.2 | 4,824 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 51.52 per share. | 09 Feb 2024 | 100 | 2,686 (0%) | 0% | 51.5 | 5,152 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,938 | 3,938 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,938 | 11,812 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 45.06 per share. | 01 Feb 2024 | 1,324 | 2,614 (0%) | 0% | 45.1 | 59,659 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 27 Dec 2023 | 7,926 | 0 (0%) | 0% | 50.0 | 396,318 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 6,800 | 75,800 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 27 Dec 2023 | 6,800 | 7,926 (0%) | 0% | 21.4 | 145,384 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 27 Dec 2023 | 5,015 | 1,126 (0%) | 0% | 50.0 | 250,796 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 27 Dec 2023 | 2,400 | 6,141 (0%) | 0% | 21.4 | 51,312 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 2,400 | 82,600 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 1,563 | 4,295 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 1,563 | 3,124 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 26.87 per share. | 11 Feb 2023 | 554 | 3,741 (0%) | 0% | 26.9 | 14,886 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 09 Feb 2023 | 931 | 2,732 (0%) | 0% | 27.5 | 25,612 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 33,500 | 33,500 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 15,750 | 15,750 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 1,563 | 4,687 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 1,563 | 1,563 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 6.10 per share. | 11 Feb 2022 | 557 | 1,006 (0%) | 0% | 6.1 | 3,398 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges